Opportunity Information: Apply for RFA AG 21 020
The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76, Independent Clinical Trial Not Allowed) is a National Institutes of Health (NIH) grant opportunity run through the National Institute on Aging (NIA) designed to accelerate the careers of early-stage physicians and other health professional investigators who are committed to aging research or aging-related diseases. The central purpose of the program is not only to strengthen a candidate's research trajectory, but also to deliberately build leadership capacity so that awardees are positioned to influence their specialty area and the broader fields of geriatrics and aging science. NIA frames this award as a way to develop researchers who can change theory, clinical practice, and real-world health outcomes for older adults by stepping into visible leadership roles.
This FOA stands out from many mentored career development awards because it targets people who are already showing signs of independence. Applicants are expected to have begun establishing their own research programs and, importantly, must demonstrate that they have already secured competitive research support as a Program Director/Principal Investigator (PD/PI) at the faculty level or have otherwise leveraged faculty-level research support to build an independent line of investigation. In practical terms, the Beeson K76 is meant for investigators who are beyond the very earliest mentored phase and are now ready to convert early independence into sustained leadership and impact. Alongside research readiness, the FOA also expects evidence of leadership in either the clinical domain or the research domain, reinforcing that this award is as much about developing scientific leaders as it is about funding a project.
The activity is categorized as a discretionary grant within the health funding area and is associated with CFDA number 93.866. The funding opportunity number is RFA-AG-21-020. While the detailed budget limits and number of awards are not specified in the provided source text, the program’s intent is clearly career development focused: supporting a structured period during which the investigator can expand research skills, strengthen a coherent aging-focused research direction, and grow leadership capabilities that translate to broader influence within academic medicine, health systems, or aging research networks.
A key restriction is embedded in the title and mechanism description: independent clinical trials are not allowed under this FOA. That generally means applicants should not propose to lead an independent clinical trial as the main award activity. The research plan should align with the FOA's non-trial expectations (or other NIH-defined allowable clinical research that does not constitute an independent clinical trial), keeping the emphasis on career and leadership development within aging-related research.
Eligibility for applicant organizations is broad and includes many types of U.S.-based entities. Eligible applicants listed include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; certain Native American tribal organizations (other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other qualifying organizations. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal government agencies, Indian/Native American Tribal Governments (other than federally recognized), and U.S. territories or possessions. This emphasis signals an interest in broad institutional participation, including organizations that serve populations historically underrepresented in biomedical research and health leadership.
At the same time, there are clear geographic and foreign involvement restrictions. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components, as defined in the NIH Grants Policy Statement, are not allowed. In other words, the applicant organization and the work supported by the award must be firmly based in eligible U.S. settings without foreign components.
The original closing date listed for this opportunity was October 21, 2022, and the FOA record shows a creation date of August 13, 2020. Taken together, this announcement describes a career development pathway aimed at a specific slice of the workforce: early-stage clinician-investigators and health professionals who are already demonstrating independent momentum, have proven they can compete for research support, and are ready for a structured boost that strengthens both their research program in aging and their ability to lead and shape the field.Apply for RFA AG 21 020
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2020-08-13.
- Applicants must submit their applications by 2022-10-21. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Previous opportunity: PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 21 020
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 21 020) also looked into and applied for these:
| Funding Opportunity |
|---|
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) Apply for RFA AG 21 021 Funding Number: RFA AG 21 021 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed) Apply for RFA NS 21 007 Funding Number: RFA NS 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) Apply for PAR 20 259 Funding Number: PAR 20 259 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support Apply for PA 20 074 Funding Number: PA 20 074 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $1,000,000 |
| Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) Apply for PAR 20 258 Funding Number: PAR 20 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA TR 20 030 Funding Number: RFA TR 20 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes (U01 Clinical Trial Not Allowed) Apply for RFA HL 21 015 Funding Number: RFA HL 21 015 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 21 024 Funding Number: PAR 21 024 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed) Apply for RFA EY 20 001 Funding Number: RFA EY 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) Apply for PAR 20 293 Funding Number: PAR 20 293 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed) Apply for PAR 20 296 Funding Number: PAR 20 296 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Request for Information (RFI) for Improved Health Service Delivery activity (IHSD) Apply for 72052120R00021 Funding Number: 72052120R00021 Agency: Haiti USAID-Port Au Prince Category: Health Funding Amount: $80,000,000 |
| HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed) Apply for RFA HL 21 016 Funding Number: RFA HL 21 016 Agency: National Institutes of Health Category: Health Funding Amount: $2,445,000 |
| Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed) Apply for PAR 20 290 Funding Number: PAR 20 290 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed) Apply for PAR 20 291 Funding Number: PAR 20 291 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) Apply for RFA TR 20 032 Funding Number: RFA TR 20 032 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Research Education Program (R25 Clinical Trial Not Allowed) Apply for PAR 20 289 Funding Number: PAR 20 289 Agency: National Institutes of Health Category: Health Funding Amount: $325,000 |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (UG3/UH3 Clinical Trial Required) Apply for RFA TR 20 031 Funding Number: RFA TR 20 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Drug Development Collaboratory (UG3/UH3 Clinical Trial Required) Apply for PAR 20 301 Funding Number: PAR 20 301 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Water Resources Management for Enhanced Water, Sanitation, and Hygiene (WRM-WASH) Apply for 72062020RFA00009 Funding Number: 72062020RFA00009 Agency: Nigeria USAID-Abuja Category: Health Funding Amount: $10,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 21 020", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.